<DOC>
	<DOCNO>NCT01607931</DOCNO>
	<brief_summary>Human volunteer stratify oral glucose tolerance status : normal glucose tolerant , impair glucose tolerant , type 2 diabetic . All subject undergo 4 experimental trial : [ 1 ] oral glucose tolerance test ( OGTT ) combine infused ingested stable isotope glucose assess glucose kinetics . [ 2 ] 1 hour bout cycle exercise 50 % maximum power output , immediately follow OGTT combine stable isotope glucose tracer use trial 1 . [ 3 ] isoglycemic clamp match plasma glucose profile measure trial 1 . [ 4 ] 1 hour bout cycle exercise 50 % maximum power output , immediately follow isoglycemic clamp match plasma glucose profile measure trial 2 . Exercise-induced change oral glucose tolerance , glucose kinetics , insulin glucagon secretion , incretin effect examine . The exercise response compare subject group different glucose tolerance status .</brief_summary>
	<brief_title>Exercise , Glucose Kinetics , Incretin Effect</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Incretins</mesh_term>
	<criteria>age 1860 year BMI 1835 kg/m2 insulin dependency pregnancy presence history chronic cardiovascular , pulmonary , hepatic , renal , hematological disease , cancer contraindication physical activity assess ECG</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Exercise</keyword>
	<keyword>Physical activity</keyword>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Obesity</keyword>
	<keyword>Incretin effect</keyword>
	<keyword>GLP-1</keyword>
	<keyword>GIP</keyword>
	<keyword>Insulin secretion</keyword>
	<keyword>Glucagon</keyword>
	<keyword>Beta-cell function</keyword>
	<keyword>Disposition Index</keyword>
</DOC>